> top > docs > PMC:1448208 > spans > 2458-3456 > annotations

PMC:1448208 / 2458-3456 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T3373 0-8 NNS denotes Patients
T3374 47-51 VBP denotes show
T3375 9-13 IN denotes with
T3376 14-18 NN denotes MSUD
T3377 18-20 , denotes ,
T3378 20-29 VBG denotes depending
T3379 30-32 IN denotes on
T3380 33-36 DT denotes the
T3381 37-45 NN denotes mutation
T3382 45-47 , denotes ,
T3383 52-60 JJ denotes variable
T3384 61-68 NNS denotes degrees
T3385 69-71 IN denotes of
T3386 72-78 NN denotes enzyme
T3387 79-89 NN denotes deficiency
T3388 90-97 VBG denotes leading
T3389 98-100 IN denotes to
T3390 101-108 JJ denotes several
T3391 128-138 NNS denotes phenotypes
T3392 109-118 JJ denotes different
T3393 119-127 JJ denotes clinical
T3394 139-140 -LRB- denotes [
T3395 140-141 CD denotes 1
T3396 141-142 -RRB- denotes ]
T3397 142-143 . denotes .
T3398 143-271 sentence denotes Approximately 75% of MSUD patients have the classic form of the disease with BCKDH activity in the range of 0–2% of normal [1].
T3399 144-157 RB denotes Approximately
T3400 158-160 CD denotes 75
T3401 160-161 NN denotes %
T3402 179-183 VBP denotes have
T3403 162-164 IN denotes of
T3404 165-169 NN denotes MSUD
T3405 170-178 NNS denotes patients
T3406 184-187 DT denotes the
T3407 196-200 NN denotes form
T3408 188-195 JJ denotes classic
T3409 201-203 IN denotes of
T3410 204-207 DT denotes the
T3411 208-215 NN denotes disease
T3412 216-220 IN denotes with
T3413 221-226 NN denotes BCKDH
T3414 227-235 NN denotes activity
T3415 236-238 IN denotes in
T3416 239-242 DT denotes the
T3417 243-248 NN denotes range
T3418 249-251 IN denotes of
T3419 252-253 CD denotes 0
T3420 254-255 CD denotes 2
T3421 253-254 SYM denotes –
T3422 255-256 NN denotes %
T3423 257-259 IN denotes of
T3424 260-266 JJ denotes normal
T3425 267-268 -LRB- denotes [
T3426 268-269 CD denotes 1
T3427 269-270 -RRB- denotes ]
T3428 270-271 . denotes .
T3429 271-360 sentence denotes These patients show markedly elevated levels of BCAA in blood and other body fluids [1].
T3430 272-277 DT denotes These
T3431 278-286 NNS denotes patients
T3432 287-291 VBP denotes show
T3433 292-300 RB denotes markedly
T3434 301-309 VBN denotes elevated
T3435 310-316 NNS denotes levels
T3436 317-319 IN denotes of
T3437 320-324 NN denotes BCAA
T3438 325-327 IN denotes in
T3439 328-333 NN denotes blood
T3440 334-337 CC denotes and
T3441 338-343 JJ denotes other
T3442 349-355 NNS denotes fluids
T3443 344-348 NN denotes body
T3444 356-357 -LRB- denotes [
T3445 357-358 CD denotes 1
T3446 358-359 -RRB- denotes ]
T3447 359-360 . denotes .
T3448 360-427 sentence denotes Besides the classic form, there are other variants of the disease.
T3449 361-368 IN denotes Besides
T3450 393-396 VBP denotes are
T3451 369-372 DT denotes the
T3452 381-385 NN denotes form
T3453 373-380 JJ denotes classic
T3454 385-387 , denotes ,
T3455 387-392 EX denotes there
T3456 397-402 JJ denotes other
T3457 403-411 NNS denotes variants
T3458 412-414 IN denotes of
T3459 415-418 DT denotes the
T3460 419-426 NN denotes disease
T3461 426-427 . denotes .
T3462 427-531 sentence denotes Patients with the intermediate form of the disease show BCKDH activity in the range of 3–30% of normal.
T3463 428-436 NNS denotes Patients
T3464 479-483 VBP denotes show
T3465 437-441 IN denotes with
T3466 442-445 DT denotes the
T3467 459-463 NN denotes form
T3468 446-458 JJ denotes intermediate
T3469 464-466 IN denotes of
T3470 467-470 DT denotes the
T3471 471-478 NN denotes disease
T3472 484-489 NN denotes BCKDH
T3473 490-498 NN denotes activity
T3474 499-501 IN denotes in
T3475 502-505 DT denotes the
T3476 506-511 NN denotes range
T3477 512-514 IN denotes of
T3478 515-516 CD denotes 3
T3479 517-519 CD denotes 30
T3480 516-517 SYM denotes –
T3481 519-520 NN denotes %
T3482 521-523 IN denotes of
T3483 524-530 JJ denotes normal
T3484 530-531 . denotes .
T3485 531-641 sentence denotes In such patients the onset of the disease is delayed, but there are persistently elevated levels of BCAA [1].
T3486 532-534 IN denotes In
T3487 577-584 VBN denotes delayed
T3488 535-539 JJ denotes such
T3489 540-548 NNS denotes patients
T3490 549-552 DT denotes the
T3491 553-558 NN denotes onset
T3492 559-561 IN denotes of
T3493 562-565 DT denotes the
T3494 566-573 NN denotes disease
T3495 574-576 VBZ denotes is
T3496 584-586 , denotes ,
T3497 586-589 CC denotes but
T3498 590-595 EX denotes there
T3499 596-599 VBP denotes are
T3500 600-612 RB denotes persistently
T3501 613-621 VBN denotes elevated
T3502 622-628 NNS denotes levels
T3503 629-631 IN denotes of
T3504 632-636 NN denotes BCAA
T3505 637-638 -LRB- denotes [
T3506 638-639 CD denotes 1
T3507 639-640 -RRB- denotes ]
T3508 640-641 . denotes .
T3509 641-799 sentence denotes Patients with the intermittent form of MSUD show BCKDH activity in the range of 5–20% and during the asymptomatic phase the blood BCAA levels are normal [1].
T3510 642-650 NNS denotes Patients
T3511 686-690 VBP denotes show
T3512 651-655 IN denotes with
T3513 656-659 DT denotes the
T3514 673-677 NN denotes form
T3515 660-672 JJ denotes intermittent
T3516 678-680 IN denotes of
T3517 681-685 NN denotes MSUD
T3518 691-696 NN denotes BCKDH
T3519 697-705 NN denotes activity
T3520 706-708 IN denotes in
T3521 709-712 DT denotes the
T3522 713-718 NN denotes range
T3523 719-721 IN denotes of
T3524 722-723 CD denotes 5
T3525 724-726 CD denotes 20
T3526 723-724 SYM denotes –
T3527 726-727 NN denotes %
T3528 728-731 CC denotes and
T3529 732-738 IN denotes during
T3530 784-787 VBP denotes are
T3531 739-742 DT denotes the
T3532 756-761 NN denotes phase
T3533 743-755 JJ denotes asymptomatic
T3534 762-765 DT denotes the
T3535 777-783 NNS denotes levels
T3536 766-771 NN denotes blood
T3537 772-776 NN denotes BCAA
T3538 788-794 JJ denotes normal
T3539 795-796 -LRB- denotes [
T3540 796-797 CD denotes 1
T3541 797-798 -RRB- denotes ]
T3542 798-799 . denotes .
T3543 799-998 sentence denotes The overall incidence of MSUD in the general population is 1:185,000 [1], and in certain population groups, such as Mennonites of Pennsylvania, the incidence is estimated to be as high as 1:176 [2].
T3544 800-803 DT denotes The
T3545 812-821 NN denotes incidence
T3546 804-811 JJ denotes overall
T3547 856-858 VBZ denotes is
T3548 822-824 IN denotes of
T3549 825-829 NN denotes MSUD
T3550 830-832 IN denotes in
T3551 833-836 DT denotes the
T3552 845-855 NN denotes population
T3553 837-844 JJ denotes general
T3554 859-860 CD denotes 1
T3555 861-868 CD denotes 185,000
T3556 860-861 SYM denotes :
T3557 869-870 -LRB- denotes [
T3558 870-871 CD denotes 1
T3559 871-872 -RRB- denotes ]
T3560 872-874 , denotes ,
T3561 874-877 CC denotes and
T3562 878-880 IN denotes in
T3563 961-970 VBN denotes estimated
T3564 881-888 JJ denotes certain
T3565 900-906 NNS denotes groups
T3566 889-899 NN denotes population
T3567 906-908 , denotes ,
T3568 908-912 JJ denotes such
T3569 913-915 IN denotes as
T3570 916-926 NNS denotes Mennonites
T3571 927-929 IN denotes of
T3572 930-942 NNP denotes Pennsylvania
T3573 942-944 , denotes ,
T3574 944-947 DT denotes the
T3575 948-957 NN denotes incidence
T3576 958-960 VBZ denotes is
T3577 971-973 TO denotes to
T3578 974-976 VB denotes be
T3579 977-979 IN denotes as
T3580 980-984 JJ denotes high
T3581 985-987 IN denotes as
T3582 988-989 CD denotes 1
T3583 990-993 CD denotes 176
T3584 989-990 SYM denotes :
T3585 994-995 -LRB- denotes [
T3586 995-996 CD denotes 2
T3587 996-997 -RRB- denotes ]
T3588 997-998 . denotes .
R383 T3423 T3422 prep of,%
R385 T3424 T3423 pobj normal,of
R386 T3425 T3426 punct [,1
R388 T3426 T3402 parataxis 1,have
R389 T3427 T3426 punct ],1
R390 T3428 T3402 punct .,have
R391 T3430 T3431 det These,patients
R392 T3431 T3432 nsubj patients,show
R393 T3433 T3434 advmod markedly,elevated
R394 T3434 T3435 amod elevated,levels
R395 T3435 T3432 dobj levels,show
R397 T3436 T3435 prep of,levels
R398 T3437 T3436 pobj BCAA,of
R399 T3438 T3432 prep in,show
R400 T3439 T3438 pobj blood,in
R402 T3440 T3439 cc and,blood
R403 T3441 T3442 amod other,fluids
R405 T3442 T3439 conj fluids,blood
R406 T3443 T3442 compound body,fluids
R407 T3444 T3445 punct [,1
R409 T3445 T3432 parataxis 1,show
R410 T3446 T3445 punct ],1
R411 T3447 T3432 punct .,show
R413 T3449 T3450 prep Besides,are
R415 T3451 T3452 det the,form
R416 T3452 T3449 pobj form,Besides
R418 T3453 T3452 amod classic,form
R419 T3454 T3450 punct ", ",are
R420 T3455 T3450 expl there,are
R422 T3456 T3457 amod other,variants
R424 T3457 T3450 attr variants,are
R425 T3458 T3457 prep of,variants
R426 T3459 T3460 det the,disease
R427 T3460 T3458 pobj disease,of
R429 T3461 T3450 punct .,are
R430 T3463 T3464 nsubj Patients,show
R432 T3465 T3463 prep with,Patients
R433 T3466 T3467 det the,form
R436 T3467 T3465 pobj form,with
R437 T3468 T3467 amod intermediate,form
R439 T3469 T3467 prep of,form
R440 T3470 T3471 det the,disease
R441 T3471 T3469 pobj disease,of
R442 T3472 T3473 compound BCKDH,activity
R443 T3473 T3464 dobj activity,show
R444 T3474 T3473 prep in,activity
R446 T3475 T3476 det the,range
R447 T3476 T3474 pobj range,in
R448 T3477 T3476 prep of,range
R450 T3478 T3479 quantmod 3,30
R451 T3479 T3481 nummod 30,%
R452 T3480 T3479 punct –,30
R454 T3481 T3477 pobj %,of
R455 T3482 T3481 prep of,%
R456 T3483 T3482 pobj normal,of
R458 T3484 T3464 punct .,show
R459 T3486 T3487 prep In,delayed
R461 T3488 T3489 amod such,patients
R462 T3489 T3486 pobj patients,In
R464 T3490 T3491 det the,onset
R465 T3491 T3487 nsubjpass onset,delayed
R467 T3492 T3491 prep of,onset
R468 T3493 T3494 det the,disease
R469 T3494 T3492 pobj disease,of
R470 T3495 T3487 auxpass is,delayed
R472 T3496 T3487 punct ", ",delayed
R473 T3497 T3487 cc but,delayed
R474 T3498 T3499 expl there,are
R476 T3499 T3487 conj are,delayed
R478 T3500 T3501 advmod persistently,elevated
R479 T3501 T3502 amod elevated,levels
R480 T3502 T3499 attr levels,are
R481 T3503 T3502 prep of,levels
R483 T3504 T3503 pobj BCAA,of
R484 T3505 T3506 punct [,1
R486 T3506 T3499 parataxis 1,are
R487 T3507 T3506 punct ],1
R488 T3508 T3499 punct .,are
R490 T3510 T3511 nsubj Patients,show
R492 T3512 T3510 prep with,Patients
R493 T3513 T3514 det the,form
R494 T3514 T3512 pobj form,with
R495 T3515 T3514 amod intermittent,form
R496 T3516 T3514 prep of,form
R498 T3517 T3516 pobj MSUD,of
R499 T3518 T3519 compound BCKDH,activity
R500 T3519 T3511 dobj activity,show
R501 T3520 T3511 prep in,show
R503 T3521 T3522 det the,range
R504 T3522 T3520 pobj range,in
R505 T3523 T3522 prep of,range
R506 T3373 T3374 nsubj Patients,show
R507 T3524 T3525 quantmod 5,20
R508 T3525 T3527 nummod 20,%
R509 T3526 T3525 punct –,20
R510 T3527 T3523 pobj %,of
R511 T3375 T3373 prep with,Patients
R512 T3528 T3511 cc and,show
R513 T3376 T3375 pobj MSUD,with
R514 T3377 T3374 punct ", ",show
R515 T3378 T3374 prep depending,show
R516 T3529 T3530 prep during,are
R517 T3530 T3511 conj are,show
R518 T3379 T3378 prep on,depending
R519 T3531 T3532 det the,phase
R520 T3532 T3529 pobj phase,during
R521 T3380 T3381 det the,mutation
R522 T3533 T3532 amod asymptomatic,phase
R523 T3534 T3535 det the,levels
R524 T3535 T3530 nsubj levels,are
R525 T3381 T3379 pobj mutation,on
R526 T3536 T3535 compound blood,levels
R527 T3537 T3535 compound BCAA,levels
R528 T3538 T3530 acomp normal,are
R529 T3382 T3374 punct ", ",show
R530 T3539 T3540 punct [,1
R531 T3540 T3530 parataxis 1,are
R532 T3383 T3384 amod variable,degrees
R533 T3541 T3540 punct ],1
R534 T3542 T3530 punct .,are
R535 T3384 T3374 dobj degrees,show
R536 T3544 T3545 det The,incidence
R537 T3545 T3547 nsubj incidence,is
R538 T3546 T3545 amod overall,incidence
R539 T3385 T3384 prep of,degrees
R540 T3548 T3545 prep of,incidence
R541 T3386 T3387 compound enzyme,deficiency
R542 T3549 T3548 pobj MSUD,of
R543 T3550 T3545 prep in,incidence
R544 T3551 T3552 det the,population
R545 T3552 T3550 pobj population,in
R546 T3553 T3552 amod general,population
R547 T3387 T3385 pobj deficiency,of
R548 T3554 T3555 nummod 1,"185,000"
R549 T3555 T3547 attr "185,000",is
R550 T3556 T3555 punct :,"185,000"
R551 T3388 T3387 acl leading,deficiency
R552 T3557 T3558 punct [,1
R553 T3558 T3547 parataxis 1,is
R554 T3559 T3558 punct ],1
R555 T3389 T3388 prep to,leading
R556 T3560 T3547 punct ", ",is
R557 T3561 T3547 cc and,is
R558 T3562 T3563 prep in,estimated
R559 T3390 T3391 amod several,phenotypes
R560 T3563 T3547 conj estimated,is
R561 T3391 T3389 pobj phenotypes,to
R562 T3564 T3565 amod certain,groups
R563 T3565 T3562 pobj groups,in
R564 T3566 T3565 compound population,groups
R565 T3392 T3391 amod different,phenotypes
R566 T3567 T3565 punct ", ",groups
R567 T3568 T3569 amod such,as
R568 T3569 T3565 prep as,groups
R569 T3570 T3569 pobj Mennonites,as
R570 T3393 T3391 amod clinical,phenotypes
R571 T3571 T3570 prep of,Mennonites
R572 T3572 T3571 pobj Pennsylvania,of
R573 T3394 T3395 punct [,1
R574 T3573 T3563 punct ", ",estimated
R575 T3574 T3575 det the,incidence
R576 T3575 T3563 nsubjpass incidence,estimated
R577 T3576 T3563 auxpass is,estimated
R578 T3395 T3374 parataxis 1,show
R579 T3577 T3578 aux to,be
R580 T3578 T3563 xcomp be,estimated
R581 T3396 T3395 punct ],1
R582 T3579 T3578 prep as,be
R583 T3580 T3579 amod high,as
R584 T3581 T3580 prep as,high
R585 T3397 T3374 punct .,show
R586 T3582 T3583 nummod 1,176
R587 T3583 T3581 pobj 176,as
R588 T3584 T3583 punct :,176
R589 T3399 T3400 advmod Approximately,75
R590 T3585 T3586 punct [,2
R591 T3586 T3563 parataxis 2,estimated
R592 T3587 T3586 punct ],2
R593 T3588 T3563 punct .,estimated
R594 T3400 T3401 nummod 75,%
R596 T3401 T3402 nsubj %,have
R602 T3403 T3401 prep of,%
R608 T3404 T3405 compound MSUD,patients
R612 T3405 T3403 pobj patients,of
R616 T3406 T3407 det the,form
R620 T3407 T3402 dobj form,have
R623 T3408 T3407 amod classic,form
R627 T3409 T3407 prep of,form
R631 T3410 T3411 det the,disease
R636 T3411 T3409 pobj disease,of
R640 T3412 T3407 prep with,form
R642 T3413 T3414 compound BCKDH,activity
R646 T3414 T3412 pobj activity,with
R649 T3415 T3414 prep in,activity
R650 T3416 T3417 det the,range
R652 T3417 T3415 pobj range,in
R656 T3418 T3417 prep of,range
R659 T3419 T3420 quantmod 0,2
R663 T3420 T3422 nummod 2,%
R667 T3421 T3420 punct –,2
R669 T3422 T3418 pobj %,of

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T3196 37-45 SO_EXT:sequence_alteration_entity_or_process denotes mutation
T3197 72-78 CHEBI_GO_SO_EXT:enzyme denotes enzyme
T3198 320-324 CHEBI:22918 denotes BCAA
T3199 328-333 UBERON:0000178 denotes blood
T3200 344-355 UBERON:0006314 denotes body fluids
T3201 632-636 CHEBI:22918 denotes BCAA
T3202 766-771 UBERON:0000178 denotes blood
T3203 772-776 CHEBI:22918 denotes BCAA

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T3110 320-324 CHEBI:22918 denotes BCAA
T3111 328-333 UBERON:0000178 denotes blood
T3112 344-355 UBERON:0006314 denotes body fluids
T3113 632-636 CHEBI:22918 denotes BCAA
T3114 766-771 UBERON:0000178 denotes blood
T3115 772-776 CHEBI:22918 denotes BCAA